Cryosite Ltd
ASX:CTE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.55
1.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cryosite Ltd
Cryosite Ltd
Common Stock
Cryosite Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cryosite Ltd
ASX:CTE
|
Common Stock
AU$3.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
Anteotech Ltd
ASX:ADO
|
Common Stock
AU$99.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Common Stock
AU$36.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Common Stock
AU$101.5m
|
CAGR 3-Years
28%
|
CAGR 5-Years
705%
|
CAGR 10-Years
N/A
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Common Stock
AU$119.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Common Stock
AU$6.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
827%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
Glance View
Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.
See Also
What is Cryosite Ltd's Common Stock?
Common Stock
3.5m
AUD
Based on the financial report for Jun 30, 2024, Cryosite Ltd's Common Stock amounts to 3.5m AUD.
What is Cryosite Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
-8%
Over the last year, the Common Stock growth was -41%. The average annual Common Stock growth rates for Cryosite Ltd have been -15% over the past three years , -10% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
